We are live on ! Find out more

Inspire Corporate Bond ETF

IBD

Market cap $503M

23.30 USD

-0.05

0.21%

At close Updated Sep 18, 2:38 PM EDT

1 day

-0.21%

5 days

-0.04%

1 month

-1.52%

3 months

-2.14%

6 months

-2.43%

Year to date

-3.76%

1 year

-4%

5 years

-11.51%

10 years

-7.17%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Inspire Corporate Bond Fund (IBD) Receives 5-star Overall Morningstar Rating™ Among 155 Corporate Bond Funds

BOISE, Idaho, Aug. 25, 2026 /PRNewswire/ -- Inspire Investing is pleased to announce that the Inspire Corporate Bond ETF (NYSE: IBD) has been awarded a 5-star Overall Morningstar Rating™ for the 5-year period out of 155 Corporate Bond funds as of 7/31/26. Morningstar's rating system evaluates funds based on their risk-adjusted returns relative to category peers, with the top 10% of funds in each category receiving a 5-star rating.

Inspire Corporate Bond Fund (IBD) Receives 5-star Overall Morningstar Rating™ Among 155 Corporate Bond Funds

Zacks Investment Research

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Zacks Investment Research

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®

AbbVie presents 18 abstracts in Crohn's disease and ulcerative colitis Breadth of data from real-world evidence and clinical trials reinforce risankizumab and upadacitinib efficacy, safety profile, and durability NORTH CHICAGO, Ill., May 5, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago.

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®

Inspire Investing Announces Lower Expense Ratios on 5 Faith-Based ETFs

BOISE, Idaho, April 28, 2026 /PRNewswire/ -- Inspire Investing, the world's largest provider of Christian ETFs, reported expense ratio reductions on five of its exchange traded funds. These reductions range from 2.7% to 7.6% for an overall average decrease of 5.3%.

Inspire Investing Announces Lower Expense Ratios on 5 Faith-Based ETFs

Zacks Investment Research

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Designed to provide broad exposure to the Investment Grade Corporate Bond ETFs category of the market, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund launched on 07/10/2017.

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Zacks Investment Research

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Designed to provide broad exposure to the Investment Grade Corporate Bond ETFs category of the market, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund launched on 07/10/2017.

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Hyper Scale: AI's Massive Financing Needs In Focus

AI development requires large projects to establish computing power. That in turn requires massive amounts of financing.

Hyper Scale: AI's Massive Financing Needs In Focus

Zacks Investment Research

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Zacks Investment Research

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.

Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?

See News Rankings

Price charts implemented using Lightweight Charts™